November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Justin Ferdinandus: BrECADD is better tolerated than eBEACOPP for patients with advanced Hodgkin Lymphoma
Jul 6, 2024, 09:58

Justin Ferdinandus: BrECADD is better tolerated than eBEACOPP for patients with advanced Hodgkin Lymphoma

Justin Ferdinandus, Resident Physician at University Hospital Cologne, shared on X:

HD21 results now finally published in The Lancet:

BrECADD is better tolerated and more efficient than eBEACOPP as PET-guided treatment for patients with adv. Hodgkin Lymphoma!”

Justin Ferdinandus

Source: Justin Ferdinandus/X